Assessment of prognostic value of baseline 18FDG PET/CT metabolic parameters (SUV max, MTV and TLG) and treatment response on 18FDG PET/CT scan in patients of Langerhan Cell histiocytosis

被引：0
|
作者：
Pereira, M. [1 ]
Shah, S. [1 ]
Puranik, A. [1 ]
Bedmutha, A. [1 ]
Agrawal, A. [1 ]
Purandare, N. [1 ]
Rangarajan, V. [1 ]
机构：
[1] HBNI, Tata Mem Hosp, Mumbai, Maharashtra, India
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2020年 / 47卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-349
引用
收藏
页码：S178 / S179
页数：2
相关论文
共 50 条
  • [21] Visualization of distal spinal cord on 18FDG PET/CT
    Greenspan, Robin
    Suprenant, Valmore
    Atem, Folefac
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [22] Neurosarcoidosis and infliximab therapy monitored by 18FDG PET/CT
    Riviere, E.
    Schwartz, P.
    Machelart, I.
    Greib, C.
    Pellegrin, J. -L.
    Viallard, J. -F.
    Lazaro, E.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2019, 112 (09) : 695 - 697
  • [23] Evaluation of 18FDG PET/CT in bladder cancer staging
    De Clermont-Gallerande, Henri
    Godbert, Yann
    Wallerand, Herve
    Laffon, Eric
    Ravaud, Alain
    Allard, Michele
    Fernandez, Philippe
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [24] Usefulness of 18FDG PET/CT in Ewing sarcoma In Morocco
    Sallak, A.
    Iris, E.
    Amal, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S512 - S512
  • [25] 18FDG PET/CT Findings in the Unusual Urachal Adenocarcinoma
    Guimaraes, Marcos Duarte
    Vieira Bitencourt, Almir Galvao
    Pereira Lima, Eduardo Nobrega
    Marchiori, Edson
    CLINICAL NUCLEAR MEDICINE, 2014, 39 (09) : 831 - 834
  • [26] Staging recurrent ovarian cancer with 18FDG PET/CT
    Dragosavac, Sanja
    Derchain, Sophie
    Caserta, Nelson M. G.
    De Souza, Gustavo
    ONCOLOGY LETTERS, 2013, 5 (02) : 593 - 597
  • [27] 18FDG CT/PET N the assessment of lung inflammation in systemic sclerosis patients
    La Corte, R.
    Prandini, N.
    Volpinari, S.
    Lo Monaco, A.
    Limpido, G.
    Bruschi, M.
    Mangherini, S.
    Roncali, M.
    Trotta, F.
    Feggi, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 104 - 104
  • [28] How much 18FDG is needed to scan a given number of oncologic patients with PET/CT?
    Speranza, A.
    Varrone, A.
    Venetucci, A.
    Storto, G.
    Panico, M.
    Russo, A.
    Pace, L.
    Salvatore, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S305 - S306
  • [29] The contribution of 18FDG PET/CT for the characterization and evaluation of the therapeutic response in histiocytoses
    Vija, L. -M.
    Bera, G.
    Haroche, J.
    Cohen, F.
    Chaumet-Riffaud, P.
    Prigent, A.
    Maksud, P.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2015, 39 (04): : 357 - 370
  • [30] Oesophageal cancer: the prognostic value of the pre-treatment 18FDG PET
    Metges, J. P.
    Volant, A.
    Lozac'h, P.
    Robazskiewicz, M.
    Bizais, Y.
    Cheze, C.
    EJC SUPPLEMENTS, 2005, 3 (02): : 214 - 214
12345